BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2025-06

225 industry Phase 2/3 trial readout(s) and 45 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2025-05 | 2025-07 →

FDA decision events

DateEventStatusCompanyDrugSource
2025-06-02Complete response lettercomplete responseResQ Pharma()) (4) (20% soybean oil emulsion), for intravenous infusionCRL 2025-06-02: ResQ Pharma NDA 217382 (()) (4) (20% soybean oil emulsion), for intravenous infusion)
2025-06-03FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2025-06-03: KEYTRUDA (BLA125514 SUPPL173)
2025-06-03FDA approvalapprovedBAYER HEALTHCARENUBEQAApproved 2025-06-03: NUBEQA (NDA212099 SUPPL8)
2025-06-05FDA approvalapprovedAZURITYXIFYRMApproved 2025-06-05: XIFYRM (NDA218395 ORIG1)
2025-06-05FDA approvalapprovedAZURITYWIDAPLIKApproved 2025-06-05: WIDAPLIK (NDA219423 ORIG1)
2025-06-06FDA approvalapprovedASTELLASVYLOYApproved 2025-06-06: VYLOY (BLA761365 SUPPL3)
2025-06-06FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2025-06-06: KEYTRUDA (BLA125514 SUPPL183)
2025-06-09FDA approvalapprovedFRESENIUS KABI USAROCURONIUM BROMIDEApproved 2025-06-09: ROCURONIUM BROMIDE (NDA217472 ORIG1)
2025-06-09FDA approvalapprovedMERCK SHARP DOHME MRKENFLONSIAApproved 2025-06-09: ENFLONSIA (BLA761432 ORIG1)
2025-06-10FDA approvalapprovedBEONE MEDICINES USA ONCBRUKINSAApproved 2025-06-10: BRUKINSA (NDA218785 ORIG1)
2025-06-10FDA approvalapprovedBEONE MEDICINES USA ONCBRUKINSAApproved 2025-06-10: BRUKINSA (NDA218785 ORIG2)
2025-06-10FDA approvalapprovedABBVIE ABBVMAVYRETApproved 2025-06-10: MAVYRET (NDA215110 SUPPL5)
2025-06-10FDA approvalapprovedABBVIE ABBVMAVYRETApproved 2025-06-10: MAVYRET (NDA209394 SUPPL19)
2025-06-10FDA approvalapprovedCYCLEHARLIKU; NITYRApproved 2025-06-10: HARLIKU; NITYR (NDA209449 SUPPL18)
2025-06-11FDA approvalapprovedNUVATION NUVBIBTROZIApproved 2025-06-11: IBTROZI (NDA219713 ORIG1)
2025-06-11FDA approvalapprovedSANOFI SNYHECTOROLApproved 2025-06-11: HECTOROL (NDA020862 SUPPL33)
2025-06-12FDA approvalapprovedPFIZER PFETALZENNAApproved 2025-06-12: TALZENNA (NDA217439 SUPPL3)
2025-06-12FDA approvalapprovedPFIZER PFETALZENNAApproved 2025-06-12: TALZENNA (NDA211651 SUPPL13)
2025-06-12FDA approvalapprovedUROGEN PHARMA URGNZUSDURIApproved 2025-06-12: ZUSDURI (NDA215793 ORIG1)
2025-06-12FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2025-06-12: KEYTRUDA (BLA125514 SUPPL180)
2025-06-16FDA approvalapprovedAZURITYARYNTAApproved 2025-06-16: ARYNTA (NDA219847 ORIG1)
2025-06-16FDA approvalapprovedGENERAL DISTRIBUTING COMPANYCARBON DIOXIDE USPApproved 2025-06-16: CARBON DIOXIDE, USP (NDA220634 ORIG1)
2025-06-16FDA approvalapprovedCSL BEHRING LLCANDEMBRYApproved 2025-06-16: ANDEMBRY (BLA761367 ORIG1)
2025-06-18FDA approvalapprovedGLAXOSMITHKLINEZEJULAApproved 2025-06-18: ZEJULA (NDA214876 SUPPL3)
2025-06-18FDA approvalapprovedMORPHOSYS US INCMONJUVIApproved 2025-06-18: MONJUVI (BLA761163 SUPPL13)
2025-06-18FDA approvalapprovedGILEAD SCIENCES INC GILDYEZTUGOApproved 2025-06-18: YEZTUGO (NDA220018 ORIG1)
2025-06-18FDA approvalapprovedGILEAD SCIENCES INC GILDYEZTUGOApproved 2025-06-18: YEZTUGO (NDA220020 ORIG1)
2025-06-18FDA approvalapprovedREGENERON PHARMACEUTICALS REGNDUPIXENTApproved 2025-06-18: DUPIXENT (BLA761055 SUPPL70)
2025-06-20Complete response lettercomplete responseCipla USA, Inc.CRL 2025-06-20: Cipla USA, Inc. NDA 210168
2025-06-20FDA approvalapprovedGILEAD SCIENCES INC GILDDESCOVYApproved 2025-06-20: DESCOVY (NDA208215 SUPPL25)
2025-06-20FDA approvalapprovedGILEAD SCIENCES INC GILDDESCOVYApproved 2025-06-20: DESCOVY (NDA208215 SUPPL23)
2025-06-20FDA approvalapprovedGILEAD SCIENCES INC GILDTYBOSTApproved 2025-06-20: TYBOST (NDA203094 SUPPL17)
2025-06-20FDA approvalapprovedGILEAD SCIENCES INC GILDTYBOSTApproved 2025-06-20: TYBOST (NDA203094 SUPPL18)
2025-06-20FDA approvalapprovedGLAXOSMITHKLINE LLCBENLYSTAApproved 2025-06-20: BENLYSTA (BLA761043 SUPPL34)
2025-06-23FDA approvalapprovedAVID RADIOPHARMS INCAMYVIDApproved 2025-06-23: AMYVID (NDA202008 SUPPL46)
2025-06-23FDA approvalapprovedGE HEALTHCAREVIZAMYLApproved 2025-06-23: VIZAMYL (NDA203137 SUPPL24)
2025-06-23FDA approvalapprovedLANTHEUS LNTHNEURACEQApproved 2025-06-23: NEURACEQ (NDA204677 SUPPL24)
2025-06-23FDA approvalapprovedDAIICHI SANKYO INCDATROWAYApproved 2025-06-23: DATROWAY (BLA761464 ORIG1)
2025-06-25Complete response lettercomplete responseSun Pharmaceutical Industries Limited(nilotinib) capsulesCRL 2025-06-25: Sun Pharmaceutical Industries Limited NDA 215644 ((nilotinib) capsules)
2025-06-26Complete response lettercomplete responseAccord BioPharma Inc.INTP1CRL 2025-06-26: Accord BioPharma Inc. BLA 761027 (INTP1)
2025-06-27Complete response lettercomplete responseUnicycive Therapeutics Inc. UNCYoxylanthanum carbonateCRL 2025-06-27: Unicycive Therapeutics Inc. NDA 218607 (oxylanthanum carbonate tablets)
2025-06-27FDA approvalapprovedAVYXA HOLDINGSAVGEMSIApproved 2025-06-27: AVGEMSI (NDA219920 ORIG1)
2025-06-27FDA approvalapprovedHIKMATYZAVANApproved 2025-06-27: TYZAVAN (NDA211962 SUPPL17)
2025-06-27FDA approvalapprovedAPRECIA PHARMSSPRITAMApproved 2025-06-27: SPRITAM (NDA207958 SUPPL27)
2025-06-27FDA approvalapprovedNOVIMMUNE S.A.GAMIFANTApproved 2025-06-27: GAMIFANT (BLA761107 SUPPL18)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2025-06 est.P2Newish Technology (Beijing) Co., Ltd.NCT03820310 Clinical Trial of Autologous Tcm Immunotherapy in ICCCholangiocarcinomaunknown20
2025-06 est.P2RedHill Biopharma Limited RDHLNCT04026984 Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 YearsTraveler's Diarrheaunknown142
2025-06 est.P2/P3Advicenne PharmaNCT04137978 Study Evaluating Patients With CystinuriaCystinuriawithdrawn
2025-06 est.P1/P2Foresee Pharmaceuticals Co., Ltd.NCT04522375 A Dose Escalation Study of FP-045 in Patients With Fanconi AnemiaFanconi Anemiawithdrawn
2025-06 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04523272 A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerAdvanced Renal Cancerunknown528
2025-06 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT04818333 A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung CancerAdvanced Non-small Cell Lung Cancerunknown157
2025-06 est.P3Cyclo Therapeutics, Inc.NCT04860960 Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1Niemann-Pick Disease, Type C1unknown94
2025-06 est.P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04971551 A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.Acute Graft-Versus-Host Diseaseunknown60
2025-06 est.P3Ascletis Pharmaceuticals Co., Ltd.NCT05118776 Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBMRecurrent Glioblastomaunknown136
2025-06 est.P3AmzellNCT05128344 A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile SpasmsSpasms, Infantilewithdrawn
2025-06 est.P1/P2Nuvation Bio Inc. NUVBNCT05191004 Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBCAdvanced Breast Cancer; Metastatic Breast Cancer; Breast Cancer; Breast Carcinoma; Cancer of the Brewithdrawn
2025-06 est.P3Evopoint Biosciences Inc.NCT05204368 Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudComplicated Urinary Tract Infection Including Acute Pyelonephritisunknown780
2025-06 est.P1/P2Binhui Biopharmaceutical Co., Ltd.NCT05232136 OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder CancerNon-muscle-invasive Bladder Cancerunknown30
2025-06 est.P2Green Cross CorporationNCT05422508 Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinaVaricellarecruiting230
2025-06 est.P3Aytu BioPharma, Inc. AYTUNCT05463679 Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.Vascular Ehlers-Danlos Syndromesuspended260
2025-06 est.P3Guangzhou Gloria Biosciences Co., Ltd.NCT05518318 GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)Classic Hodgkin's Lymphoma; Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphomaunknown60
2025-06 est.P1/P2Kartos Therapeutics, Inc.NCT05705466 Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung CancerNon Small Cell Lung Cancerwithdrawn
2025-06 est.P2AkesoNCT05859750 A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic CancerPancreatic Cancerrecruiting78
2025-06 est.P2EverImmuneNCT05865730 A Study of Oncobax®-AK in Patients With Advanced Solid TumorsCarcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lungunknown122
2025-06 est.P3FutureChemNCT05936658 [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate CancerHigh Risk Prostate Carcinomaactive not recruiting138
2025-06 est.P3ISU Abxis Co., Ltd.NCT06081062 Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry DiseaseFabry Diseaseunknown24
2025-06 est.P2ReAlta Life Sciences, Inc.NCT06175065 Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseAcute Exacerbation of Chronic Obstructive Pulmonary Diseaseactive not recruiting24
2025-06 est.P3Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT06216392 Phase III Study of GR1802 Injection in Patients With Atopic DermatitisAtopic Dermatitisunknown450
2025-06 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06218771 A Study of TQB3454 Tablets in Patients With Blood TumorsAcute Myeloid Leukemia; Myelodysplastic Syndromesunknown80
2025-06 est.P3Biomedica Foscama S.p.A. Industria Chimico-FarmaceuticaNCT06296212 Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.Pneumonia; Myocardial Injuryunknown178
2025-06 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06361927 A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC PatientsNSCLCunknown120
2025-06 est.P3Boston Medical GroupNCT06425224 Effectiveness and Safety of TENS Therapy for Premature EjaculationPremature Ejaculation; Sex Disorder; TENrecruiting129
2025-06 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06493760 A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer PatientsMetastatic Colorectal Cancerrecruiting130
2025-06 est.P2OrsoBio, IncNCT06564584 Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLDHypertriglyceridemia; Nonalcoholic Fatty Liver Diseaseunknown30
2025-06 est.P3Jina Pharmaceuticals Inc.NCT06608641 Efficacy and Safety of Endoxifen in Bipolar I Disorder PatientsBipolar 1 Disorderunknown490
2025-06 est.P2Shandong New Time Pharmaceutical Co., LTDNCT06782594 A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal DysfunctionPostoperative Gastrointestinal Dysfunctionunknown150
2025-06 est.P1/P2Ace Cells Lab LimitedNCT06787482 Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and DystrophiesRetinitis Pigmentosa (RP); Age Related Macular Degeneration; Diabetic Retinopathyrecruiting100
2025-06 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06957379 Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard HR+/HER2- Advanced/Metastatic Breast Canceractive not recruiting78
2025-06-01P3EMSNCT02483936 Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlArterial Hypertensionwithdrawn
2025-06-01P3EMSNCT02493322 Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlEssential Arterial Hypertensionwithdrawn
2025-06-01 est.P1/P2CARsgen Therapeutics Co., Ltd.NCT04404595 Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive CancersGastric Cancer; Pancreatic Canceractive not recruiting110
2025-06-01 est.P3FutureChemNCT05004285 Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI DiagnosisHigh Risk Prostate Carcinomaactive not recruiting398
2025-06-01 est.P3Betta Pharmaceuticals Co., Ltd.NCT05341583 Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung CancerNon-small Cell Lung Cancerunknown202
2025-06-01 est.P1/P2FutureChemNCT05458544 [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and ApplicationMetastatic Castration-resistant Prostate Cancerunknown26
2025-06-01 est.P1/P2Ranok Therapeutics (Hangzhou) Co., Ltd.NCT05487170 A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)Advanced Solid Tumor; DLBCLrecruiting32
2025-06-01 est.P1/P2TYK Medicines, IncNCT05675605 A Study of TY-1091 in Patients With Advanced Solid TumorsRET-altered Non Small Cell Lung Cancer; Medullary Thyroid Cancer; RET-altered Papillary Thyroid Cancunknown248
2025-06-01 est.P1/P2Tyligand Bioscience (Shanghai) LimitedNCT05842785 TSN222 in Subjects With Advanced Solid Tumors or LymphomasHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphomaunknown162
2025-06-01 est.P3Genuine Research Center, EgyptNCT05876585 Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and VoGastroenteritisunknown126
2025-06-01 est.P2Oticara Australia PTY LTDNCT05882903 The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus SurgeryChronic Rhinosinusitis (Diagnosis)recruiting24
2025-06-01 est.P2Lipella Pharmaceuticals, Inc. LIPONCT06233591 Evaluating LP-10 in Subjects With OLPOral Lichen Planusunknown24
2025-06-01 est.P2RemeGen Co., Ltd.NCT06389006 To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positiveBreast Cancerrecruiting79
2025-06-01 est.P3Beijing Minhai Biotechnology Co., LtdNCT06608199 A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 VaccinePneumococcal Vaccines; Pneumococcal Infectionsrecruiting500
2025-06-02P2Regeneron Pharmaceuticals REGNNCT05353166 REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge PressureHeart Failurecompleted59
2025-06-02P2OsivaxNCT06582277 Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836Vaccine-Preventable Diseases; Influenzacompleted117
2025-06-02P2Dryox HealthNCT06645509 Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of VictorhyPalmar Hyperhidrosisterminated58
2025-06-02P2Cerus Corporation CERSNCT06697223 A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED IlluminatorHealthy Subjectscompleted40
2025-06-03P2/P3Acacia Pharma LtdNCT05546359 Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric PatientsNausea and Vomiting, Postoperativecompleted453
2025-06-03P3Takeda TAKNCT06470828 A Study of TAK-861 for the Treatment of Narcolepsy Type 1Narcolepsy Type 1completed168
2025-06-03P3GlaxoSmithKlineNCT06614725 A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age aRespiratory Syncytial Virus Infectionscompleted751
2025-06-03P3HTA Co., Ltd.NCT07764653 Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast CancerSentinel Nodes; Breast Cancercompleted213
2025-06-04P3Sun Pharmaceutical Industries LimitedNCT04314531 Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)Active Psoriatic Arthritisactive not recruiting296
2025-06-04P2Esperion Therapeutics, Inc.NCT05694260 A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path Hypercholesterolemiacompleted31
2025-06-04P2Celldex Therapeutics CLDXNCT05774184 A Study of CDX-0159 in Patients With Eosinophilic EsophagitisEosinophilic Esophagitiscompleted86
2025-06-04P3Takeda TAKNCT06505031 A Study of TAK-861 in People With Narcolepsy Type 1Narcolepsy Type 1completed105
2025-06-04P2AstraZeneca AZNNCT06644924 A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaAsthmacompleted118
2025-06-05P3AbbVie ABBVNCT04166058 Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-CIrritable Bowel Syndrome With Constipation; Functional Constipationcompleted381
2025-06-05P2Jiangsu HengRui Medicine Co., Ltd.NCT04571710 A Trial of SHR1258 in Patients With Biliary Tract CancerBiliary Tract Cancerwithdrawn
2025-06-05P2/P3GlaxoSmithKlineNCT04655976 Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung CanceLung Cancer, Non-Small Cellactive not recruiting758
2025-06-05P2Pfizer PFENCT05879718 A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.Lupus Erythematosus, Systemic; Lupus Erythematosus, Cutaneousterminated8
2025-06-05P3Eli Lilly and Company LLYNCT06010004 A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 DiabetesType 2 Diabetescompleted401
2025-06-05P2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT06012812 A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic DermatitisModerate to Severe Atopic Dermatitiscompleted79
2025-06-05P2Jetema USA Inc.NCT06246552 Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar LinesGlabellar Linescompleted480
2025-06-05P3Vigonvita Life SciencesNCT06301854 Long-term Safety of TPN171H Tablet in Erectile Dysfunction.Erectile Dysfunctioncompleted472
2025-06-06P3Merck Sharp & Dohme LLC MRKNCT03924895 Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in ParticipUrinary Bladder Cancer, Muscle-invasiveactive not recruiting595
2025-06-06P3BiocadNCT05802225 Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast CancerBreast Canceractive not recruiting398
2025-06-06P1/P2Incyte Corporation INCYNCT05949632 A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsAdvanced Solid Tumorsterminated5
2025-06-06P1/P2Tasly Pharmaceutical Group Co., LtdNCT06238687 A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid TumorsNeoplasm Malignantcompleted19
2025-06-06P2Clexio Biosciences Ltd.NCT06340958 A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderAdjunctive Treatment of Major Depressive Disorder (MDD)completed99
2025-06-09P3AbbVie ABBVNCT04064827 A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With SChronic Kidney Disease (CKD); Secondary Hyperparathyroidism (SHPT)terminated2
2025-06-09P3Hoffmann-La RocheNCT05123703 A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRRelapsing-remitting Multiple Sclerosisactive not recruiting188
2025-06-09P2AbbVie ABBVNCT05760313 A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are TreateFunctional Constipationcompleted19
2025-06-09P3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05861102 Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)Ankylosing Spondylitiscompleted265
2025-06-09P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT06361875 A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AboveInfluenza Immunization; Healthy Volunteerscompleted908
2025-06-09P2Shijiazhuang Yiling Pharmaceutical Co. LtdNCT06755944 A Phase Ⅱb Study of XY03-EA Tablets in Acute Ischemic StrokeStroke, Ischemiccompleted360
2025-06-10P3Jiangsu HengRui Medicine Co., Ltd.NCT04906993 Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical CancerCervical Canceractive not recruiting443
2025-06-10P2Xencor, Inc. XNCRNCT05005728 XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancercompleted72
2025-06-10P1/P2Sixera PharmaNCT05211830 A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton SyndromeNetherton Syndromecompleted9
2025-06-10P3Ahn-Gook Pharmaceuticals Co.,LtdNCT05503953 Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLSEssential Hypertensioncompleted318
2025-06-10P2Eli Lilly and Company LLYNCT06901349 A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 DiabetesObesity; Overweightwithdrawn
2025-06-11P3Sanofi SNYNCT02859896 Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on DialysisSecondary Hyperparathyroidism-Chronic Kidney Diseaseterminated21
2025-06-11P2Nuvation Bio Inc. NUVBNCT04919811 Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLCNon Small Cell Lung Canceractive not recruiting217
2025-06-11P2Hoffmann-La RocheNCT05075824 A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOESickle Cell Diseasecompleted95
2025-06-11 est.P3Shanghai Mabgeek Biotech.Co.LtdNCT06026891 Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic DermatitisAtopic Dermatitisunknown498
2025-06-11P2Eli Lilly and Company LLYNCT06074562 A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathycompleted404
2025-06-11P3Pfizer PFENCT06325657 A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their InfantsRespiratory Syncytial Viruscompleted681
2025-06-11P3Sanofi Pasteur, a Sanofi Company SNYNCT06705140 A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersRSV Immunisation; Healthy Volunteersterminated42
2025-06-11P1/P2Genmab GMABNCT06771921 A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid TumorsMalignant Solid Tumorterminated3
2025-06-12P3Eli Lilly and Company LLYNCT04255433 A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesType 2 Diabetes Mellituscompleted13299
2025-06-12P1/P2GlaxoSmithKlineNCT05298254 A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in PartHerpes Simplexcompleted504
2025-06-12 est.P2Shanghai Jiatan Pharmatech Co., LtdNCT06117540 A Study of WX390 in Patients With Advanced Solid TumorsSolid Tumorunknown70
2025-06-13P2/P3Gilead Sciences GILDNCT02016924 Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVAcquired Immune Deficiency Syndrome (AIDS); HIV Infectionsactive not recruiting133
2025-06-13P2Merck Sharp & Dohme LLC MRKNCT03516981 A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)Advanced Non-Small Cell Lung Cancercompleted245
2025-06-13P1/P2Repare TherapeuticsNCT04497116 Study of RP-3500, Camonsertib, in Advanced Solid TumorsAdvanced Solid Tumorcompleted276
2025-06-13P1/P2Sanofi SNYNCT05086315 First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-ceAcute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndromes; Blastic terminated101
2025-06-13P2iTeos TherapeuticsNCT05403385 Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung CancerMetastatic NSCLC - Non-Small Cell Lung Cancer; Locally Advanced NSCLC - Non-Small Cell Lung Canceractive not recruiting36
2025-06-13P3Click Therapeutics, Inc. CLIKNCT06067984 An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of SchizophreniaSchizophrenia; Negative Symptoms in Schizophreniacompleted73
2025-06-13P3Shenzhen HighTide Biopharmaceutical Ltd.NCT06415773 Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With MetforminT2DM (Type 2 Diabetes Mellitus)completed367
2025-06-13P1/P2Arcturus Therapeutics, Inc. ARCTNCT06602531 Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in AdultsInfluenza, Humancompleted212
2025-06-13P3Zhejiang Huahai Pharmaceutical Co., Ltd.NCT07253207 Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive DisorderMajor Depressive Disorder (MDD)completed392
2025-06-15P3Hoffmann-La RocheNCT04660344 A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive FollowingMuscle-invasive Bladder Cancercompleted761
2025-06-15 est.P3Beijing Biostar Pharmaceuticals Co., Ltd.NCT05673590 Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerLocally Advanced or Metastatic Non-Small Cell Lung Cancerunknown612
2025-06-15 est.P3Beijing Biostar Pharmaceuticals Co., Ltd.NCT05673629 Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast CancerBreast Cancerunknown552
2025-06-15P2/P3Quit GeniusNCT05748639 Integrated Digital Intervention for Alcohol Use DisorderAlcohol Use Disordercompleted242
2025-06-15 est.P2Apex Labs Ltd.NCT06141876 Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSDPost-traumatic Stress Disorder; Depressionunknown160
2025-06-15 est.P1/P2Qilu Pharmaceutical Co., Ltd.NCT06394713 A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant TumorsAdvanced Malignant Neoplasmnot yet recruiting60
2025-06-16P2Axalbion SANCT04866563 A Study of Efficacy and Safety of AX-8 in Chronic CoughChronic Coughcompleted108
2025-06-16P3Braintree LaboratoriesNCT05587309 A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisErosive Esophagitiscompleted1250
2025-06-16P3AstraZeneca AZNNCT05943106 BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC ParticipantsNon-Muscle- Invasive Bladder Canceractive not recruiting100
2025-06-16P2/P3Zhuhai Trinomab Pharmaceutical Co., Ltd.NCT06083623 A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in InfantsRespiratory Syncytial Virus Infectionscompleted2282
2025-06-16P2Genentech, Inc.NCT06137183 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)Ulcerative Colitisterminated79
2025-06-16P2Vigonvita Life SciencesNCT06206720 A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSVRespiratory Syncytial Virus Infectioncompleted60
2025-06-17P1/P2Takeda TAKNCT04844073 A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic CancerSquamous Cell Cancer of Head and Neck (SCCHN); Non-small Cell Lung Cancer (NSCLC); Colorectal Cancerterminated95
2025-06-17P2Kite, A Gilead CompanyNCT04880434 Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)Relapsed/Refractory Mantle Cell Lymphomacompleted95
2025-06-17P2Metro International Biotech, LLCNCT05878119 Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training ProgramHealthycompleted124
2025-06-17P2BeiGeneNCT05909904 A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma; Head and Neck Cancercompleted160
2025-06-17P3Renibus Therapeutics, Inc.NCT06021457 Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac SurgeryPost-Operative Complications in Cardiac Surgerycompleted454
2025-06-17P1/P2Merck Sharp & Dohme LLC MRKNCT06242691 Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)Advanced Solid Tumorscompleted13
2025-06-17P3Immedica Pharma ABNCT06582524 Pegzilarginase in Subjects <24 Months Old With Arginase 1 DeficiencyArginase 1 Deficiencycompleted3
2025-06-18P3CStone PharmaceuticalsNCT04194775 A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular CarcinomaHepatocellular Carcinomaactive not recruiting534
2025-06-18P3Capricor Inc. CAPRNCT05126758 A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyMuscular Dystrophies; Muscular Dystrophy, Duchenne; Muscular Disorders, Atrophic; Muscular Diseases;active not recruiting106
2025-06-18P1/P2Xindu Pty LtdNCT05344157 A First-in-Human Study of XSTEM-OA in Patients With Knee OsteoarthritisOsteoarthritis, Kneecompleted24
2025-06-18P2Sanofi SNYNCT06073093 A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid ArthritisRheumatoid Arthritiscompleted264
2025-06-18P3Hanmi Pharmaceutical Company Limited HAFCNCT06595004 A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain PatientsChronic Low-back Paincompleted310
2025-06-18P2Aldeyra Therapeutics, Inc. ALDXNCT06685692 A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)Alcohol Hepatitiscompleted4
2025-06-19P3Merz Pharmaceuticals GmbHNCT03992404 Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic BrainLower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injuryactive not recruiting603
2025-06-19P2Archivel Farma S.L.NCT04919239 Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)Tuberculosis, Pulmonarycompleted140
2025-06-19P3Rose Research Center, LLCNCT05205811 The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic CigaretteSmoking Cessationcompleted180
2025-06-19P3Novartis Pharmaceuticals NVSNCT05653219 A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsPrimary Immune Thrombocytopeniaactive not recruiting152
2025-06-19P3Eli Lilly and Company LLYNCT05931380 A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity DiseaseObesitycompleted238
2025-06-19P2Alnylam Pharmaceuticals ALNYNCT06272487 Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive MedicatiHigh Cardiovascular Risk; Hypertensioncompleted375
2025-06-19P2Alkermes, Inc. ALKSNCT06358950 A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)Narcolepsy Type 1completed92
2025-06-19P2Procter and Gamble PGNCT06892834 Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.Gingivitiscompleted120
2025-06-19P3Medprin Regenerative Medical Technologies Co., Ltd.NCT07754344 Dural Medical Adhesive for Watertight Sealing in Dural RepairSpinal Dural Defect; Cerebrospinal Fluid Leakage; Spinal Neurosurgerycompleted141
2025-06-20P2Mapi Pharma Ltd.NCT03362294 Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMSPrimary Progressive Multiple Sclerosisterminated30
2025-06-20P1/P2Nacuity Pharmaceuticals, Inc.NCT04355689 Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher SyndromeUsher Syndromescompleted49
2025-06-20P3Hansa Biopharma ABNCT04935177 Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney TxKidney Transplantation in Highly Sensitized Patientscompleted64
2025-06-20P3Amgen AMGNNCT05052801 Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionGastric Cancer; Gastroesophageal Junction Adenocarcinomacompleted547
2025-06-20P2EMD Serono Research & Development Institute, Inc.NCT05327530 A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder MedleyLocally Advanced or Metastatic Urothelial Carcinomaactive not recruiting256
2025-06-20P3Click Therapeutics, Inc. CLIKNCT05838625 Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of SchizophreniaSchizophreniacompleted464
2025-06-20P3CSL BehringNCT06524739 Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTSPost-COVID Postural Orthostatic Tachycardia Syndrometerminated16
2025-06-23P2Merck Sharp & Dohme LLC MRKNCT04924101 Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung CanSmall Cell Lung Cancercompleted122
2025-06-23P2Enanta Pharmaceuticals, Inc ENTANCT05568706 A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.RSV Infectioncompleted187
2025-06-23P3Hansa Biopharma ABNCT05679401 A Study With Imlifidase in Anti-GBM DiseaseAnti-Glomerular Basement Membrane Disease; Anti-Glomerular Basement Membrane Antibody Disease; Goodpterminated50
2025-06-23 est.P3Lipogems International spaNCT06121882 Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee OsteoarthritisKnee Osteoarthritis; Osteo Arthritis Kneeactive not recruiting173
2025-06-23P2Engrail Therapeutics INCNCT06653296 A Dose-Response Safety Study of ENX-102 in Patients With GADGeneral Anxiety Disordercompleted38
2025-06-23P3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07253584 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin ThHyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemiacompleted720
2025-06-24P1/P2Cybrexa TherapeuticsNCT04902872 Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsSolid Tumor, Adult; Epithelial Ovarian Cancer; Small Cell Lung Carcinoma; Breast Cancer; Colorectal completed69
2025-06-24P1/P2GlaxoSmithKlineNCT05073003 A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and InfantsDiarrhoeacompleted551
2025-06-24P3Abivax S.A. ABVXNCT05507203 ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1Ulcerative Colitiscompleted639
2025-06-24P3Abivax S.A. ABVXNCT05507216 ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2Ulcerative Colitiscompleted636
2025-06-24P3Hoffmann-La RocheNCT05595642 A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)completed1380
2025-06-24P2Innostellar Biotherapeutics Co.,LtdNCT06196840 Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)Neovascular Age-Related Macular Degenerationactive not recruiting50
2025-06-24P1/P2Asahi Kasei Therapeutics, ABNCT06274489 A Study to Evaluate Setanaxib in Patients With Alport SyndromeAlport Syndromecompleted20
2025-06-24P2TORQURNCT06319794 Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic KeratosisActinic Keratosiscompleted46
2025-06-24P2Viking Therapeutics, Inc. VKTXNCT06828055 VK2735 for Weight Management Phase 2 (Venture Oral Dosing)Weight Losscompleted280
2025-06-25P1/P2Hangzhou Hanx Biopharmaceuticals, Ltd.NCT05189093 Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory LymphomaRelapsed/Refractory Lymphomacompleted48
2025-06-25P3aTyr Pharma, Inc. ATYRNCT05415137 Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisPulmonary Sarcoidosiscompleted268
2025-06-25P2AbbVie ABBVNCT05443724 A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaSchizophreniaterminated698
2025-06-25P2EMD Serono Research & Development Institute, Inc.NCT05650567 Study of M5049 in DM and PM Participants (NEPTUNIA)Dermatomyositis; Polymyositisterminated20
2025-06-25P3Almirall, S.A.NCT05990725 Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisAtopic Dermatitis; Eczemacompleted260
2025-06-25 est.P3Tasly Pharmaceutical Group Co., LtdNCT06697886 A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common ColdCommon Coldrecruiting480
2025-06-25P3CelltrionNCT06738719 A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid ArthritisModerately to Severely Active Rheumatoid Arthritiscompleted192
2025-06-26P2Ionis Pharmaceuticals, Inc. IONSNCT05143957 A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia VeraPhlebotomy Dependent Polycythemia Veracompleted50
2025-06-26P3Sinotau Pharmaceutical GroupNCT05459844 A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETsNeuroendocrine Tumorscompleted196
2025-06-26P2Ryan DackorNCT05617313 Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung CancerNon Small Cell Lung Cancer; Metastatic NSCLC; Recurrent Non Small Cell Lung Cancerterminated21
2025-06-26P2Kowa Research Institute, Inc.NCT06247735 Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to UrsodeoxychoPrimary Biliary Cholangitiscompleted46
2025-06-26P2J2H BiotechNCT06297434 Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASHNon-alcoholic Steatohepatitiscompleted87
2025-06-27 est.P2Leadiant Biosciences, Inc.NCT04231266 Multi-Center Study of ManNAc for GNE MyopathyGNE Myopathyactive not recruiting54
2025-06-27P2Allist Pharmaceuticals, Inc.NCT05466149 Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 InsertionNSCLCactive not recruiting100
2025-06-27P3Novartis Pharmaceuticals NVSNCT05842954 Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaUncomplicated Plasmodium Falciparum Malariacompleted1720
2025-06-27P2ModernaTX, Inc.NCT06097299 A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial VirusRespiratory Syncytial Viruscompleted349
2025-06-27 est.P3Innovent Biologics (Suzhou) Co. Ltd.NCT06164873 A Study of IBI362 9 mg in Chinese Adults With ObesityObesityunknown462
2025-06-27P2Merck Sharp & Dohme LLC MRKNCT06482112 Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)Metabolic Dysfunction-Associated Steatotic Liver Disease; Non-alcoholic Fatty Liver Disease; Nonalcocompleted124
2025-06-27P2Manistee TherapeuticsNCT06728553 Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in AdultsMigrainecompleted78
2025-06-29P3Bausch & Lomb Incorporated BLCONCT06803654 A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With OOcular Rednesscompleted578
2025-06-30P1/P2eyeDNA TherapeuticsNCT03328130 Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B GeneRetinitis Pigmentosaterminated19
2025-06-30P3Hoffmann-La RocheNCT04548999 A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)Multiple Sclerosisactive not recruiting769
2025-06-30 est.P2Telios Pharma, Inc.NCT04655118 Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic MastocytosisMyelofibrosis; Indolent Systemic Mastocytosisunknown121
2025-06-30 est.P1/P2Simcha IL-18, Inc.NCT04787042 Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067Cancer; Solid Tumor; Melanoma; Renal Cell Carcinoma; Triple-negative Breast Cancer; Non Small Cell Lrecruiting316
2025-06-30P1/P2Genmab GMABNCT04824794 GEN3014 Trial in Relapsed or Refractory Hematologic MalignanciesRelapsed or Refractory Multiple Myeloma (RRMM); Diffuse Large B Cell Lymphoma (DLBCL); Acute Myeloidterminated130
2025-06-30P1/P2Shanghai Escugen Biotechnology Co., LtdNCT04892342 Study of ESG401 in Adults With Solid TumorsNeoplasms, Breast; Neoplasms, Lung; Neoplasms,Colorectal; Neoplasms, Bladder; Neoplasm of Stomach; Ncompleted156
2025-06-30P3AstraZeneca AZNNCT04964934 Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)ER-Positive HER2-Negative Breast Canceractive not recruiting315
2025-06-30P2Pharvaris Netherlands B.V. PHVSNCT05047185 Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type IIHereditary Angioedema; Hereditary Angioedema Type I; Hereditary Angioedema Type II; Hereditary Angioterminated34
2025-06-30P3Beijing InnoCare Pharma Tech Co., Ltd.NCT05051891 A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoTreatment-naїve Mantle Cell Lymphomacompleted3
2025-06-30P2Recursion Pharmaceuticals Inc. RXRXNCT05085561 The Symptomatic Cerebral Cavernous Malformation Trial of REC-994Cerebral Cavernous Malformationcompleted62
2025-06-30P3United Therapeutics UTHRNCT05255991 Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis; Interstitial Lung Diseasecompleted597
2025-06-30P3Fresenius Medical Care North America FMSNCT05339139 SAfety of Regional Citrate Anticoagulation (SARCA Study)Acute Kidney Injury; ESRDcompleted32
2025-06-30P2Coherus Oncology, Inc. CHRSNCT05359861 Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular CarcinomaHepatocellular Carcinomaterminated30
2025-06-30P1/P2SwanBio Therapeutics, Inc.NCT05394064 A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)AMN; AMN Gene Mutation; X-ALDterminated9
2025-06-30P3PharmaEssentiaNCT05481151 A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PVPolycythemia Veraactive not recruiting111
2025-06-30P2SOFIENCT05641896 Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersGastrointestinal Cancers; Cholangiocarcinoma; Gastric Cancer; Colorectal Cancer; Pancreatic Ductal Acompleted112
2025-06-30P1/P2Syndax Pharmaceuticals SNDXNCT05731947 Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid TumorsColorectal Cancer; Solid Tumorsterminated41
2025-06-30 est.P3Fosun Adgenvax Biopharmaceutical Co.,Ltd.NCT05759520 Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in InfantsStreptococcus Pneumoniae Infectionunknown1800
2025-06-30 est.P1/P2Coherent Biopharma (Hefei) Co., Ltd. COHRNCT05830097 A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsCancer, Breast; Cancer, Lung; Cancer of Pancreas; Cancer of Esophagus; Cancer Colorectalunknown260
2025-06-30P2Novartis Pharmaceuticals NVSNCT05834738 Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA NephropathyIgA Nephropathy; Immunoglobulin A Nephropathycompleted54
2025-06-30 est.P2Neuren Pharmaceuticals LimitedNCT05879614 An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)Prader-Willi Syndromewithdrawn
2025-06-30 est.P2WestVac Biopharma Co., Ltd.NCT05911048 A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster VaccinationCOVID-19unknown3100
2025-06-30 est.P3WestVac Biopharma Co., Ltd.NCT05911061 A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster VaccinationCOVID-19unknown4950
2025-06-30 est.P2NorthSea Therapeutics B.V.NCT05919680 A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).Intestinal Failure Associated Liver Diseaserecruiting36
2025-06-30P2NiKang Therapeutics, Inc.NCT05935748 Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)ccRCC; Clear Cell Renal Cell Carcinoma; Kidney Cancer; Kidney Neoplasms; Renal Cancer; Renal Neoplasterminated18
2025-06-30 est.P2Hansoh BioMedical R&D CompanyNCT06052423 ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung CancerExtensive Stage Small Cell Lung Cancer (ES-SCLC)withdrawn
2025-06-30 est.P2Beijing Yongtai Ruike Biotechnology Company LtdNCT06179524 CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALLRelapsed B-cell Acute Lymphoblastic Leukemia; Refractory B-cell Acute Lymphoblastic Leukemiarecruiting100
2025-06-30 est.P2Convalife (Shanghai) Co., Ltd.NCT06183736 CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN DeficiencyAdvanced Solid Tumorsnot yet recruiting98
2025-06-30 est.P2Anavex Life Sciences Corp. AVXLNCT06245213 A Study of ANAVEX3-71 in Adults With SchizophreniaSchizophreniaactive not recruiting71
2025-06-30P2Ryvu Therapeutics SANCT06268574 Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AMLAcute Myeloid Leukemia (AML); High-risk Myelodysplastic Syndrometerminated62
2025-06-30P3argenx ARGXNCT06298552 A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized MyastheGeneralized Myasthenia Gravis; gMG; Myasthenia Gravis, Generalized; Myasthenia Gravisactive not recruiting119
2025-06-30 est.P2AmtixBio Co., Ltd.NCT06327295 A Study of ATB1651 in Adults With Mild to Moderate OnchomycosisOnychomycosisrecruiting120
2025-06-30 est.P1/P2Norroy Bioscience Co., LTDNCT06383052 A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPCMetastatic Castration-resistant Prostate Canceractive not recruiting30
2025-06-30 est.P2Hansoh BioMedical R&D CompanyNCT06393673 A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal WomenVasomotor Symptomsunknown195
2025-06-30P3Taizhou Mabtech Pharmaceutical Co.,LtdNCT06398652 Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque PsoriasisPsoriasiscompleted336
2025-06-30 est.P1/P2YolTech Therapeutics Co., LtdNCT06539208 A Phase I/IIa,Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics ofTransthyretin Amyloidosis Polyneuropathy; Transthyrexin Amyloidosis Cardiomyopathyunknown31
2025-06-30P2Zhejiang Doer Biologics Co., Ltd.NCT06555640 A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaSevere Hypertriglyceridemiacompleted79
2025-06-30 est.P2LG ChemNCT06618196 Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeDiphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type B Infectionunknown336
2025-06-30 est.P1/P2MAXVAX Biotechnology Limited Liability CompanyNCT06642558 Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and AboveRespiratory Syncytial Virus (RSV)active not recruiting522
2025-06-30P2Guangdong Raynovent Biotech Co., LtdNCT06656026 Pharmacokinetics,Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza AInfluenza acompleted72
2025-06-30 est.P2JemincareNCT06664125 Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with HyperphosphatemiaHyperphosphatemiaunknown50
2025-06-30 est.P3Vanda Pharmaceuticals VNDANCT06701396 Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 VariantSleep Wake Disorders; Sleep Disorders, Circadian Rhythm; Chronobiology Disorders; Gene Mutations andrecruiting60
2025-06-30 est.P2AkesoNCT06756126 A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)Atopic Dermatitisnot yet recruiting24
2025-06-30P2SpinogenixNCT06903286 Extension Study of Participants From SPG302-ALS-001Amyotrophic Lateral Sclerosis (ALS)terminated16
2025-06-30 est.P2Livzon Pharmaceutical Group Inc.NCT06963320 Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee ArthroplastyCirculatory Diseaserecruiting320

← 2025-05 | 2025-07 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.